EUDA Health Holdings Limited Ordinary Shares (EUDA) is a publicly traded Healthcare sector company. As of May 21, 2026, EUDA trades at $18.00 with a market cap of $36.47M and a P/E ratio of -8.79. EUDA moved +6.57% today. Year to date, EUDA is -60.70%; over the trailing twelve months it is -76.83%. Its 52-week range spans $5.26 to $126.00. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces EUDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EUDA Health Faces Nasdaq $35M Market-Value Deficiency, 180-Day Deadline: EUDA Health failed to maintain a $35 million minimum market value of listed securities over 32 consecutive business days under Nasdaq rules. Nasdaq has given a 180-day compliance window until October 20, 2026 to regain compliance by closing above $35 million market value for ten consecutive days or face delisting.
| Metric | Value |
|---|---|
| Price | $18.00 |
| Market Cap | $36.47M |
| P/E Ratio | -8.79 |
| EPS | $-2.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $126.00 |
| 52-Week Low | $5.26 |
| Volume | 956 |
| Avg Volume | 0 |
| Revenue (TTM) | $9.84M |
| Net Income | $-24.95M |
| Gross Margin | 34.09% |
1 analysts cover EUDA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.75.